Discover the complete record of transactions filed by Malkiel Burton G, 董事. Director active across 1 company, notably Theravance Biopharma, Inc.. Aggregated, 1 filings have been logged. Activity tracked since 26 April 2022. The latest transaction was filed on 26 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Burton G. Malkiel is a Board Member at Theravance Biopharma, Inc. As a board member, he plays a key role in overseeing the company's activities and making strategic decisions. His experience in the biopharmaceutical field is an asset in guiding the company towards innovation.